InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
InflaRx Enterprise Value: 5.359M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 5.359M |
May 16, 2024 | -5.240M |
May 15, 2024 | -8.184M |
May 14, 2024 | -6.418M |
May 13, 2024 | -17.02M |
May 10, 2024 | -21.14M |
May 09, 2024 | -19.96M |
May 08, 2024 | -19.96M |
May 07, 2024 | -17.61M |
May 06, 2024 | -14.37M |
May 03, 2024 | -9.362M |
May 02, 2024 | -9.362M |
May 01, 2024 | -7.595M |
April 30, 2024 | -9.951M |
April 29, 2024 | -8.773M |
April 26, 2024 | -12.31M |
April 25, 2024 | -8.773M |
April 24, 2024 | -10.54M |
April 23, 2024 | -10.54M |
April 22, 2024 | -9.951M |
April 19, 2024 | -11.13M |
April 18, 2024 | -16.43M |
April 17, 2024 | -16.13M |
April 16, 2024 | -13.48M |
April 15, 2024 | -8.773M |
Date | Value |
---|---|
April 12, 2024 | -2.296M |
April 11, 2024 | 0.0594M |
April 10, 2024 | -1.118M |
April 09, 2024 | 4.770M |
April 08, 2024 | -1.118M |
April 05, 2024 | 0.6483M |
April 04, 2024 | 1.237M |
April 03, 2024 | 0.6483M |
April 02, 2024 | 0.0594M |
April 01, 2024 | -1.118M |
March 31, 2024 | 0.0594M |
March 28, 2024 | -9.107M |
March 27, 2024 | -9.107M |
March 26, 2024 | -9.107M |
March 25, 2024 | -9.107M |
March 22, 2024 | -12.05M |
March 21, 2024 | -9.107M |
March 20, 2024 | -0.2744M |
March 19, 2024 | -0.2744M |
March 18, 2024 | -11.46M |
March 15, 2024 | -6.752M |
March 14, 2024 | -10.28M |
March 13, 2024 | -6.752M |
March 12, 2024 | -7.340M |
March 11, 2024 | -4.396M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-92.22M
Minimum
Sep 27 2019
876.18M
Maximum
May 21 2019
19.00M
Average
2.739M
Median
Enterprise Value Benchmarks
Affimed NV | 12.80M |
MorphoSys AG | 2.801B |
BioNTech SE | 5.173B |
Immatics NV | 520.46M |
CureVac NV | 335.02M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -10.49M |
Revenue (Quarterly) | 0.0391M |
Total Expenses (Quarterly) | 13.60M |
EPS Diluted (Quarterly) | -0.1847 |
Gross Profit Margin (Quarterly) | -511.9% |
Profit Margin (Quarterly) | -26.80K% |
Earnings Yield | -47.88% |